À¯·´ÀÇ Á¤¹ÐÀÇ·á ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, ±¹°¡º° - ºÐ¼®°ú ¿¹Ãø(2024-2033³â)
Europe Precision Medicine Software Market: Focus on Product Type, Application, End User, and Country - Analysis and Forecast, 2024-2033
»óǰÄÚµå : 1606243
¸®¼­Ä¡»ç : BIS Research Inc.
¹ßÇàÀÏ : 2024³â 12¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,702,000
PDF and Excel (1-3 User License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 3¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,900 £Ü 7,089,000
PDF and Excel (Global License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

À¯·´ÀÇ Á¤¹ÐÀÇ·á ¼ÒÇÁÆ®¿þ¾î ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 4¾ï 6,090¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù.

ÀÌ ½ÃÀåÀº 2024-2033³â 11.47%ÀÇ CAGR·Î È®´ëÇϸç, 2033³â¿¡´Â 12¾ï 2,470¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´ ½ÃÀå¿¡¼­ Á¤¹ÐÀÇ·á ¼ÒÇÁÆ®¿þ¾î¶õ ÇコÄɾ¼­ Á¤¹ÐÀÇ·á ±¸ÇöÀ» Áö¿øÇϱâ À§ÇØ °í¾ÈµÈ ÷´Ü µðÁöÅÐ Åø ¹× ¿ëµµ¸¦ ÀǹÌÇÕ´Ï´Ù. ÀÌ °³ÀÎÈ­ Á¢±Ù¹ýÀº À¯ÀüÇÐ, »ýȰ½À°ü, ȯ°æ, ºÐÀÚ ¶Ç´Â ¼¼Æ÷ ÇÁ·ÎÆÄÀÏÀ» Æ÷ÇÔÇÑ °³º° ȯÀÚÀÇ Æ¯¼º¿¡ ¸ÂÃá Ä¡·á¿Í ÀÇ»ç°áÁ¤¿¡ ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
¿¹Ãø ±â°£ 2024-2033³â
2024³â Æò°¡¾× 4¾ï 6,090¸¸ ´Þ·¯
2033³â ¿¹Ãø 12¾ï 2,470¸¸ ´Þ·¯
CAGR 11.47%

À¯·´ÀÇ Á¤¹ÐÀÇ·á ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀº µ¥ÀÌÅÍ ºÐ¼®, À¯ÀüüÇÐ, ¸ÂÃãÇü ÇコÄɾî Àü·« ½ÃÀå °³Ã´À¸·Î Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. Á¤¹ÐÀÇ·á ¼ÒÇÁÆ®¿þ¾î´Â ȯÀÚ °³°³ÀÎÀÇ À¯ÀüÀÚ ÇÁ·ÎÆÄÀÏ, »ýȰ½À°ü, ȯ°æÀû Á¶°Ç¿¡ µû¶ó ÀÇ·á ¼±Åðú Ä¡·á¸¦ ¸ÂÃãÈ­Çϱâ À§ÇØ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ ±â¼úÀº µ¥ÀÌÅͺ£À̽º ÀÇ»ç°áÁ¤À» °¡´ÉÇÏ°Ô ÇÔÀ¸·Î½á ȯÀÚ °á°ú, Ä¡·á È¿°ú ¹× Áø´Ü Á¤È®µµ¸¦ Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù.

À¯·´ÀÇ °­·ÂÇÑ ÇコÄÉ¾î ½Ã½ºÅÛ°ú µðÁöÅÐ Çコ ±¸»ó¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡·Î Á¤¹ÐÀÇ·á ¼ÒÇÁÆ®¿þ¾îÀÇ µµÀÔÀÌ °¡¼ÓÈ­µÇ°í ÀÖÀ¸¸ç, Horizon Europe°ú °°Àº ÇÁ·Î±×·¥À» ÅëÇØ À¯·´ Àü¿ªÀÇ Á¤ºÎ¿Í Á¶Á÷ÀÌ À¯ÀüÀÚ ¿¬±¸¿Í Á¤¹ÐÀÇ·á ºÐ¾ß¸¦ ÃÖ¿ì¼± °úÁ¦·Î »ï°í ÀÌ ºÐ¾ßÀÇ Çõ½ÅÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ ºÐ¾ßÀÇ Çõ½ÅÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´×(ML)ÀÇ ÅëÇÕÀº ¼ÒÇÁÆ®¿þ¾îÀÇ ±â´ÉÀ» ´õ¿í Çâ»ó½ÃÄÑ ½Ç½Ã°£ µ¥ÀÌÅÍ ºÐ¼®°ú ¸ÂÃãÇü Ä¡·á °èȹÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù.

À¯·´¿¡¼­´Â ¾à¹°À¯ÀüüÇÐ, ¸¸¼ºÁúȯ °ü¸®, Èñ±ÍÁúȯ ¹ß°ß, Á¾¾çÇÐÀÌ Á¤¹ÐÀÇ·á ¼ÒÇÁÆ®¿þ¾îÀÇ ÁÖ¿ä ¿ëµµ Áß ÇϳªÀÔ´Ï´Ù. ¹ÙÀÌ¿ÀÀÎÆ÷¸Åƽ½º ¹× ºòµ¥ÀÌÅÍ ½ÃÀå °³Ã´°ú ÇÔ²² Á¤¹ÐÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã ¹®Á¦, ³ôÀº µµÀÔ ºñ¿ë µîÀÇ Àå¾Ö¹°¿¡µµ ºÒ±¸ÇÏ°í ½ÃÀå È®´ë°¡ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù.

À¯·´ÀÇ Á¤¹ÐÀÇ·á ¼ÒÇÁÆ®¿þ¾î ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, ½ÃÀåÀÇ °³¿ä¿Í Á¦Ç° À¯Çüº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, ±¹°¡º° µ¿Çâ ¹× ½ÃÀå¿¡ Âü¿©ÇÏ´Â ±â¾÷ÀÇ °³¿ä µîÀ» Á¦°øÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

°³¿ä

Á¦1Àå ½ÃÀå

Á¦2Àå Áö¿ª

Á¦3Àå ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ±â¾÷ °³¿ä

Á¦4Àå Á¶»ç ¹æ¹ý

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Introduction to Europe Precision Medicine Software Market

The Europe precision medicine software market was valued at $460.9 million in 2024 and is expected to reach $1,224.7 million by 2033, growing at a CAGR of 11.47% between 2024 and 2033. In the Europe market, precision medicine software refers to advanced digital tools and applications designed to support the implementation of precision medicine in healthcare. This personalized approach focuses on tailoring medical treatments and decisions to individual patient characteristics, including genetics, lifestyle, environment, and molecular or cellular profiles.

Market Introduction

KEY MARKET STATISTICS
Forecast Period2024 - 2033
2024 Evaluation$460.9 Million
2033 Forecast$1,224.7 Million
CAGR11.47%

The market for precision medicine software in Europe is expanding significantly due to developments in data analytics, genomics, and tailored healthcare strategies. In order to customize medical choices and treatments to each patient's unique genetic profile, lifestyle, and environmental circumstances, precision medicine software is essential. By enabling data-driven decision-making, this technology enhances patient outcomes, treatment effectiveness, and diagnostic precision.

Precision medicine software adoption is being accelerated by Europe's strong healthcare system and rising investments in digital health initiatives. Through programs like Horizon Europe, governments and organizations throughout the continent are giving genetic research and precision healthcare top priority, which is encouraging innovation in the field. The software's capabilities are further improved by the integration of artificial intelligence (AI) and machine learning (ML), which permits real-time data analysis and customized treatment planning.

In Europe, pharmacogenomics, chronic disease management, uncommon disease detection, and oncology are among the main uses of precision medicine software. The increased emphasis on precision healthcare, along with developments in bioinformatics and big data, is propelling market expansion despite obstacles such data privacy issues and high implementation costs.

The market for precision medicine software is expected to be crucial in improving patient care and advancing personalized medicine, as Europe continues to lead the world in the adoption of cutting-edge healthcare technologies.

Market Segmentation

Segmentation 1: by Delivery Mode

Segmentation 2: by Application

Segmentation 3: by End User

Segmentation 4: by Country

How can this report add value to an organization?

Product/Innovation Strategy: The Europe precision medicine software market has been segmented based on various categories, such as product type, application, and end user.

Competitive Strategy: The Europe precision medicine software market is a highly fragmented market, with many smaller and private companies constantly entering the market. Key players in the precision medicine software market analyzed and profiled in the study involve established players that offer various kinds of products.

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

Table of Contents

Executive Summary

Scope and Definition

1 Markets

2 Regions

3 Markets Competitive Benchmarking & Company Profiles

4 Research Methodology

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â